Viewing Study NCT01083368


Ignite Creation Date: 2025-12-24 @ 5:42 PM
Ignite Modification Date: 2025-12-30 @ 12:50 PM
Study NCT ID: NCT01083368
Status: COMPLETED
Last Update Posted: 2019-08-21
First Post: 2010-03-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Temsirolimus and Bevacizumab in Hormone-Resistant Metastatic Prostate Cancer That Did Not Respond to Chemotherapy
Sponsor: Case Comprehensive Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adenocarcinoma of the prostate View
None hormone-resistant prostate cancer View
None recurrent prostate cancer View
None stage IV prostate cancer View